Addressing tumor blood vessels

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486 · see citing works

Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262 · see citing works

αv Integrins as receptors for tumor targeting by circulating ligands

Pasqualini, R., Koivunen, E., & Ruoslahti, E. I. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-542 · Cited by 742 · see citing works

Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature

Huang, X., Molema, G., King, S., Watkins, L. R., Edgington, T. S., & Thorpe, P. E. (1997) · Science · doi:10.1126/science.275.5299.547 · Cited by 477 · see citing works

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti‐cancer therapeutic agents

Kerbel, R. S. (1991) · BioEssays · doi:10.1002/bies.950130106 · Cited by 441 · see citing works

Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas.

Singh, R. K., Gutman, M., BUCANA, C. D., Sanchez, R. R., Llansa, N., & Fidler, I. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4562 · Cited by 437 · see citing works

Vascular attack as a therapeutic strategy for cancer

Denekamp, J. (1990) · Cancer and Metastasis Reviews · doi:10.1007/bf00046365 · Cited by 264 · see citing works

Structure–function relationships in eukaryotic nuclei

Jackson, D. A. (1991) · BioEssays · doi:10.1002/bies.950130102 · Cited by 137 · see citing works

Clinical significance of the determination of angiogenesis in human breast cancer: Update of the biological background and overview of the vicenza studies

Gasparini, G. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00376-0 · Cited by 68 · see citing works

Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model

Arap, W., Pasqualini, R., & Ruoslahti, E. I. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,040 · see citing works

Adipose tissue remodeling and obesity

Sun, K., Kusminski, C. M., & Scherer, P. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45887 · Cited by 1,941 · see citing works

Reversal of obesity by targeted ablation of adipose tissue

Kolonin, M. G., Saha, P., Chan, L., Pasqualini, R., & Arap, W. (2004) · Nature Medicine · doi:10.1038/nm1048 · Cited by 596 · see citing works

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth

Niethammer, A. G., Xiang, R., Becker, J. C., Wodrich, H., Pertl, U., Karsten, G., Eliceiri, B. P., & Reisfeld, R. A. (2002) · Nature Medicine · doi:10.1038/nm1202-794 · Cited by 400 · see citing works

The influence of the microenvironment on the malignant phenotype

Park, C. C., Bissell, M. J., & Barcellos-Hoff, M. H. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01756-1 · Cited by 398 · see citing works

Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model.

Byrne, A. T., Ross, L. H., Holash, J., Nakanishi, M., Hu, L., Hofmann, J., Yancopoulos, G. D., & Jaffe, R. B. (2003) · PubMed · Cited by 310 · see citing works

Interleukin‐18 acts as an angiogenesis and tumor suppressor

Cao, R., Farnebo, J., Kurimoto, M., & Cao, Y. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2195 · Cited by 209 · see citing works

Angiogenesis, vascular endothelial growth factor and the endometrium

Smith, S. K. (1998) · Human Reproduction Update · doi:10.1093/humupd/4.5.509 · Cited by 209 · see citing works

Probing the structural and molecular diversity of tumor vasculature

Pasqualini, R., Arap, W., & McDonald, D. M. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02429-2 · Cited by 205 · see citing works

A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2

Suarez, S., Pieren, M., Cariolato, L., Arn, S., Hoffmann, U., Bogucki, A., Manlius, C., Wood, J. M., & Ballmer‐Hofer, K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6254-9 · Cited by 198 · see citing works

Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes

McDevitt, M. R., McDevitt, M. R., Ruggiero, A., Villa, C. H., Holland, J. P., Sprinkle, S. R., May, C., Lewis, J. S., & Scheinberg, D. A. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s13300 · Cited by 171 · see citing works

Angiogenesis in ovarian follicular and luteal development

Hazzard, T. M., & Stouffer, R. L. (2000) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.2000.0133 · Cited by 154 · see citing works

Major Abdominal Surgery Increases Plasma Levels of Vascular Endothelial Growth Factor

Belizon, A., Balık, E., Feingold, D. L., Bessler, M., Arnell, T. D., Forde, K. A., Horst, P. K., Jain, S., Cekic, V., Kirman, I., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000225272.52313.e2 · Cited by 110 · see citing works

Evaluation of the anti‐vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI

Maxwell, R. J., Wilson, J., Prise, V. E., Vojnovic, B., Rustin, G. J. S., Lodge, M. A., & Tozer, G. M. (2002) · NMR in Biomedicine · doi:10.1002/nbm.754 · Cited by 104 · see citing works

Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors

Ferrari, N., Glod, J. W., Lee, J. K., Kobiler, D., & Fine, H. A. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301883 · Cited by 87 · see citing works

Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis

Xiang, R., Luo, Y., Niethammer, A. G., & Reisfeld, R. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00613.x · Cited by 80 · see citing works

Modulation of Human Colon Tumor-Stromal Interactions by the Endothelin System

Egidy, G., Juillerat‐Jeanneret, L., Jeannin, J., Korth, P., Bosman, F. T., & Pinet, F. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64825-0 · Cited by 78 · see citing works

Phage Therapy in the Era of Synthetic BiologyPreprint

Barbu, E. M., Cady, K. C., & Hubby, B. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023879 · Cited by 69 · see citing works

Vaccines With Interleukin-12–Transduced Acute Myeloid Leukemia Cells Elicit Very Potent Therapeutic and Long-Lasting Protective Immunity

Dunussi‐Joannopoulos, K., Runyon, K., Erickson, J., Schaub, R. G., Hawley, R. G., & Leonard, J. P. (1999) · Blood · doi:10.1182/blood.v94.12.4263.424k30_4263_4273 · Cited by 67 · see citing works

Mechanistic insights on the inhibition of tumor angiogenesis

Jiménez, B. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090000178 · Cited by 59 · see citing works

Early Induction of Angiogenetic Signals in Gliomas of GFAP-v-src Transgenic Mice

Theurillat, J.-P. P., Hainfellner, J. A., Maddalena, A. S., Weissenberger, J., & Aguzzi, A. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65303-5 · Cited by 54 · see citing works

Persistent elevation of plasma vascular endothelial growth factor levels during the first month after minimally invasive colorectal resection

Belizon, A., Balık, E., Horst, P. K., Feingold, D. L., Arnell, T. D., Azarani, T., Cekic, V., Skitt, R., Kumara, S., & Whelan, R. L. (2008) · Surgical Endoscopy · doi:10.1007/s00464-007-9725-7 · Cited by 49 · see citing works

Colorectal Resection is Associated With Persistent Proangiogenic Plasma Protein Changes

Kumara, H. M. C. S., Feingold, D. L., Kalady, M. F., Dujovny, N., Senagore, A. J., Hyman, N., Cekic, V., & Whelan, R. L. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181a6cd72 · Cited by 48 · see citing works

Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors

Malonne, H., Langer, I., Robert Kiss, A., & Atassi, G. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1026443925807 · Cited by 46 · see citing works

Tumor Vasculature Targeted Therapies

Molema, G., Meijer, D. K. F., & de Leij, L. F. M. H. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00011-2 · Cited by 45 · see citing works

Spatially regulated differentiation of endometrial vascular smooth muscle cells

Kohnen, G. (2000) · Human Reproduction · doi:10.1093/humrep/15.2.284 · Cited by 44 · see citing works

The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation

Wang, L.-F., Liu, Y.-S., Yang, B., Li, P., Cheng, X.-S., Xiao, C.-X., Liu, J.-J., Li, S., Ren, J.-L., & Guleng, B. (2017) · Oncogene · doi:10.1038/onc.2017.359 · Cited by 44 · see citing works

Potential tumor-targeting peptide vector of histidylated oligolysine conjugated to a tumor-homing RGD motif

Aoki, Y., Hosaka, S., Kawa, S., & Kiyosawa, K. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700362 · Cited by 44 · see citing works

EFFECTS OF HYPERTHERMIA AND TUMOUR NECROSIS FACTOR ON INFLAMMATORY CYTOKINE SECRETION AND PROCOAGULANT ACTIVITY IN ENDOTHELIAL CELLS

Gnant, M., Turner, E. M., & Alexander, H. R. (2000) · Cytokine · doi:10.1006/cyto.1999.0568 · Cited by 44 · see citing works

T cell–mediated suppression of angiogenesis results in tumor protective immunity

Zhou, H., Luo, Y., Mizutani, M., Mizutani, N., Reisfeld, R. A., & Xiang, R. (2005) · Blood · doi:10.1182/blood-2005-03-0969 · Cited by 43 · see citing works

Bacteriophage-Derived Vectors for Targeted Cancer Gene Therapy

Pranjol, M. Z. I., & Hajitou, A. (2015) · Viruses · doi:10.3390/v7010268 · Cited by 38 · see citing works

Vaccination with Viable Human Umbilical Vein Endothelial Cells Prevents Metastatic Tumors by Attack on Tumor Vasculature with Both Cellular and Humoral Immunity

Chen, X.-Y., Zhang, W. J., Zhang, W., Wu, S., Bi, F., Su, Y., Tan, X., Liu, J., & Zhang, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1105 · Cited by 38 · see citing works

DNA vaccines suppress tumor growth and metastases by the induction of anti‐angiogenesis

Reisfeld, R. A., Niethammer, A. G., Luo, Y., & Xiang, R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00137.x · Cited by 36 · see citing works

On target with tumor blood vessel markers

Zetter, B. R. (1997) · Nature Biotechnology · doi:10.1038/nbt1197-1243 · Cited by 34 · see citing works

Osteosarcoma cells induce endothelial cell proliferation during neo‐angiogenesis

de Nigris, F., Mancini, F. P., Schiano, C., Infante, T., Zullo, A., Minucci, P. B., Al-Omran, M. A., Giordano, A., & Claudio Napoli, A. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24234 · Cited by 34 · see citing works

A Potent Integrin Antagonist from a Small Library of Cyclic RGD Pentapeptide Mimics Including Benzyl‐Substituted Azabicycloalkane Amino Acids

Arosio, D., Belvisi, L., Colombo, L., Colombo, M., Invernizzi, D., Manzoni, L., Potenza, D., Serra, M., Castorina, M., Pisano, C., et al. (2008) · ChemMedChem · doi:10.1002/cmdc.200800143 · Cited by 31 · see citing works

Pharmacological aspects of targeting cancer gene therapy to endothelial cells

Sedlacek, H. H. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00113-x · Cited by 26 · see citing works

Embryonic central nervous system angiogenesis does not involve blood‐borne endothelial progenitors

Kurz, H., Korn, J., Eggli, P. S., Huang, R., & Christ, B. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1066 · Cited by 25 · see citing works

Plasma Concentrations of Angiogenesis-related Molecules in Patients with Pancreatic Cancer

Sakamoto, H., Kimura, H., Sekijima, M., Matsumoto, K., Arao, T., Chikugo, T., Yamada, Y., Kitano, M., Ito, A., Takeyama, Y., et al. (2011) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyr178 · Cited by 24 · see citing works

The significance of immunohistochemistry in the diagnosis and therapy of neoplasms

Bödey, B. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.4.371 · Cited by 24 · see citing works

Angiogenesis in head and neck squamous cell carcinoma

Homer, J. J., Greenman, J., & Stafford, N. (2000) · Clinical Otolaryngology · doi:10.1046/j.1365-2273.2000.00356.x · Cited by 23 · see citing works

FLK-1-based minigene vaccines induce T cell-mediated suppression of angiogenesis and tumor protective immunity in syngeneic BALB/c mice

Luo, Y., Markowitz, D., Xiang, R., Zhou, H., & Reisfeld, R. A. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.10.043 · Cited by 20 · see citing works

Cyclic RGD Peptides Containing Azabicycloalkane Reverse‐Turn Mimics

Belvisi, L., Caporale, A., Colombo, M., Manzoni, L., Potenza, D., Scolastico, C., Castorina, M., Cati, M., Giannini, G., & Pisano, C. (2002) · Helvetica Chimica Acta · doi:10.1002/hlca.200290017 · Cited by 20 · see citing works

Pericytes in experimental MDA-MB231 tumor angiogenesis

Kurz, H., Lauer, D., Papoutsi, M., Christ, B., & Wilting, J. (2002) · Histochemistry and Cell Biology · doi:10.1007/s00418-002-0388-0 · Cited by 20 · see citing works

DNA Vaccines Designed to Inhibit Tumor Growth by Suppression of Angiogenesis

Reisfeld, R. A., Niethammer, A. G., Luo, Y., & Xiang, R. (2004) · International Archives of Allergy and Immunology · doi:10.1159/000077009 · Cited by 20 · see citing works

Colorectal resection, both open and laparoscopic-assisted, in patients with benign indications is associated with proangiogenic changes in plasma angiopoietin 1 and 2 levels

Kumara, H. M. C. S., Hoffman, A., Kim, I. Y., Feingold, D. L., Dujovny, N., Kallady, M., Luchtefeld, M. A., & Whelan, R. L. (2008) · Surgical Endoscopy · doi:10.1007/s00464-008-0132-5 · Cited by 19 · see citing works

Selection of recombinant phages binding to pathological endothelial and tumor cells of rat glioblastoma by in-vivo display

Schluesener, H. J., & Xianglin, T. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.06.010 · Cited by 19 · see citing works

Perioperative GMCSF limits the proangiogenic plasma protein changes associated with colorectal cancer resection

Kumara, H. M. C. S., Kirman, I., Feingold, D. L., Cekic, V., Nasar, A., Arnell, T. D., Balık, E., Hoffman, A., Baxter, R., Conte, S., et al. (2008) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2008.07.012 · Cited by 18 · see citing works

Percutaneous microwave ablation (MWA) increased the serum levels of VEGF and MMP-9 in Stage I non-small cell lung cancer (NSCLC)

Ni, Y., Ye, X., Wan, C., Ni, Q., Yang, X., Huang, G., Li, W., Wang, J., Han, X., Wei, Z., et al. (2017) · International Journal of Hyperthermia · doi:10.1080/02656736.2017.1284350 · Cited by 15 · see citing works

Attenuation of photodynamically induced apoptosis by an RGD containing peptide

Allen, C. M., Sharman, W. M., Madeleine, C. L., van Lier, J. E., & WEBER, J. M. (2002) · Photochemical & Photobiological Sciences · doi:10.1039/b109979e · Cited by 14 · see citing works

Population pharmacokinetic analysis of free and bound aflibercept in patients with advanced solid tumors

Thai, H., Veyrat‐Follet, C., Mentré, F., & Comets, E. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2182-1 · Cited by 13 · see citing works

Expression and Functional Characterization of Tumor-Targeted Fusion Protein Composed of NGR Peptide and 15-kDa Actin Fragment

Lei, H., Cao, P., Miao, G., Lin, Z., & Diao, Z. (2010) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-009-8901-8 · Cited by 12 · see citing works

Sprouting angiogenesis versus co-option in tumor angiogenesis

de Waal, R. M. W., & Leenders, W. P. J. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7311-3_5 · Cited by 12 · see citing works

DNA Vaccines Suppress Angiogenesis and Protect Against Growth of Breast Cancer Metastases

Mizutani, N., Luo, Y., Mizutani, M., Reisfeld, R., & Xiang, R. (2004) · Breast Disease · doi:10.3233/bd-2004-20110 · Cited by 11 · see citing works

Platelet-Derived Growth Factor (Subtype BB) Is Elevated in Patients with Colorectal Carcinoma

Belizon, A., Balık, E., Horst, P. K., Kumara, H. M. C. S., Nasar, A., & Whelan, R. L. (2009) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181a0b388 · Cited by 11 · see citing works

The Rat Subcutaneous Air Sac Model: A Quantitative Assay of Antiangiogenesis in Induced Vessels

Lichtenberg, J., Hjarnaa, P. V., Kristjansen, P. E. G., Hansen, D., & Binderup, L. (1999) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1999.tb02108.x · Cited by 11 · see citing works

Beyond Anatomy

Calvo, B. F., & Semelka, R. C. (1999) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30231-x · Cited by 10 · see citing works

Human papillomavirus in a necessary cause of invasive cervical cancer worldwide

(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140 · see citing works

Incidence and management of ZIv-aflibercept related toxicities in colorectal cancer

Saif, M. W. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i5.1028 · Cited by 8 · see citing works

Angiogenesis Switch Pathways

Piulats, J., & Mitjans, F. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-470-4_11 · Cited by 7 · see citing works

Angiogenesis inhibitor TNP-470 during bone marrow transplant: safety in a preclinical model.

Stern, J. W., Fang, J., Shusterman, S., Pierson, G., Barr, R. D., Pawel, B., Diller, L., & Grupp, S. A. (2001) · PubMed · Cited by 6 · see citing works

Minimally invasive colon resection for malignant colonic conditions is associated with a transient early increase in plasma sVEGFR1 and a decrease in sVEGFR2 levels after surgery

Kumara, H. M. C. S., Cabot, J. C., Hoffman, A., Luchtefeld, M. A., Kalady, M. F., Hyman, N., Feingold, D. L., Baxter, R., & Whelan, R. L. (2009) · Surgical Endoscopy · doi:10.1007/s00464-009-0575-3 · Cited by 6 · see citing works

A phase I and pharmacokinetic study of afilbercept with FOLFIRI: comparison of Chinese and Caucasian populations

Xu, J., Li, Y., Sun, X. G., Zhang, D., Liu, R., Ziti‐Ljajic, S., Shi, D., Xue, F., Bail, N. L., & Xu, R. (2017) · Investigational New Drugs · doi:10.1007/s10637-016-0421-0 · Cited by 5 · see citing works

Angiogenesis in Endometriosis

Mueller, M. D., & Taylor, R. N. (2001) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-0213-4_13 · Cited by 4 · see citing works

Immune Responses in Glioblastoma: an Avenue to Effective Cancer Therapy or a Mere Epiphenomenon?

Schluesener, H. J., Meyermann, R., & Deininger, M. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-09525-6_13 · Cited by 3 · see citing works

Genetic instability and tumor cell variation

Hemstreet, G. P. (1998) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8946-9_10 · Cited by 3 · see citing works

Ligand-directed tumor targeting with hybrid viral phage nanoparticles

Dalal, B., Quinn, T. J., Foster, L., Lin, M. I., Matthews, M., & Yuhan, B. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813689-8.00013-6 · Cited by 2 · see citing works

Vom Tumornekrosefaktor zum TRAIL-AMAIZe: Antitumoral wirksame Zytokine der zweiten Generation

Wajant, H., & Pfizenmaier, K. (2001) · Oncology Research and Treatment · doi:10.1159/000055157 · Cited by 2 · see citing works

Phase I Dose-Escalation Study of Aflibercept Plus Docetaxel in Nasopharyngeal Carcinoma and Other Solid Tumors

Huang, Y., Zou, B.-Y., Zhao, L.-P., Zhao, H.-Y., Zhao, Y., Xue, C., Zhang, J.-W., Xu, F., Chen, L.-K., Liu, J., et al. (2014) · Future Oncology · doi:10.2217/fon.14.206 · Cited by 1 · see citing works

The molecular imaging suite: applications in nanotechnology, targeted imaging and cell tracking

Ruggiero, A. (2012) · RePub (Erasmus University Rotterdam) · Cited by 1 · see citing works

A Mouse Model for the Study of Factors Affecting Angiogenesis

Lichtenberg, J., & Larsson, L. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.900310.x · Cited by 1 · see citing works

Development and Evaluation of Paclitaxel-Loaded Liposomal Formulations for Targeted Drug Delivery to Breast Cancer

Kannan, V. (2010) · doi:10.21007/etd.cghs.2010.0158 · Cited by 1 · see citing works

Temperature-Sensitive Src-Transformed Mdck Cells nn 3d Cultures as a Model of Malignant Transformation of Epithelial Cells

Töyli, M. (2011) · Työväentutkimus Vuosikirja

The Impact of Surgery on Angiogenesis

Belizon, A., & Whelan, R. L. (2007) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2007.10.007

Cirurgião diante das novas terapias para o tratamento do câncer

Fructuoso, P. C., Maia, A. M., & Accetta, I. (2001) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/s0100-69912001000500010

Cytokine Targeted Treatments for Lung Cancer

Patel, J. D. (2005) · Cancer treatment and research · doi:10.1007/0-387-24361-5_12

The marriage of cancer vaccines and antiangiogenesis

Schlom, J. (2005) · Blood · doi:10.1182/blood-2005-06-2541

Antiangiogenic cancer therapy using peptide vaccine for patients with advanced pancreatic cancer

Miyazawa, M., & Yamaue, H. (2010) · Suizo · doi:10.2958/suizo.25.53

A novel double-targeted bacteriophage vector for systemic cancer gene therapy

Kia, A. (2012) · doi:10.25560/11085

Novel roles for basement membrane collagens : isoform-specific functions of collagen XVIII in adipogenesis, fat deposition and eye development, and effects of the collagen IV-derived matricryptin arresten on oral carcinoma growth and invasion

Aikio, M. (2013)

Angiogenesis Inhibitor TNP-470 During Bone Marrow Transplant and in Minimal Residual Disease

Fang, J., Stern, J. W., Shusterman, S., Alcorn, K., Pierson, G., Barr, R., Pawel, B., Diller, L., Maris, J. M., & Grupp, S. A. (2003) · Springer eBooks · doi:10.1007/978-3-642-55774-3_34

Role of tumor suppressor ING4 in human cutaneous melanoma pathogenesis and progression

Li, J. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0071472

In-vitro-Untersuchung eines Zellmodells für die Entwicklung von Sonden in der molekularen Bildgebung und Therapie : Expression endothelialer Marker in einer Endothelzelllinie

Keil, J. M. (2004)

Literatur

Wick, M. W., Pinggera, W., & Lehmann, P. (2002) · Springer eBooks · doi:10.1007/978-3-7091-6143-2_12

References

Wick, M. W., Lehmann, P., & Pinggera, W. (2003) · Springer eBooks · doi:10.1007/978-3-7091-3719-2_12

Phase I study of aflibercept in combination with docetaxel in Japanese patients with advanced solid malignancies

Sunakawa, Y., Takahashi, K., Kawaguchi, O., & Yamamoto, N. (2022) · Investigational New Drugs · doi:10.1007/s10637-022-01267-x

Angiogenesis Switch Pathways

Piulats, J., & Mitjans, F. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-222-7_11

Stem Cells and Their Niches in Angiogenesis: Vascular Endothelial Stem Cells, Hematopoietic Progenitors and Hematopoietic Effector Cells

Fang, S. (2014) · Työväentutkimus Vuosikirja

MECHANISMS OF MITOCHONDRIA-MEDIATED APOPTOSIS INDUCED BY CYTOTOXIC STRESS

Shelton, S. N. (2010) · KU ScholarWorks (The University of Kansas)

[Tumor angiogenesis and its inhibitors].

Shibuya, M. (2012) · PubMed

Beyond starving cancer: anti-angiogenic therapy

Hida, K., Maishi, N., Matsuda, A., & Yu, L. (2023) · Journal of Medical Ultrasonics · doi:10.1007/s10396-023-01310-1 · Cited by 13 · see citing works

Modulation of Tumor Vasculature Network: Key Strategies

Taleb, M., Mohammadkhani, N., Bahreini, F., Ovais, M., & Nie, G. (2022) · Small Structures · doi:10.1002/sstr.202100164 · Cited by 16 · see citing works

Tumor Angiogenesis Inhibitors

Киселев, С. М., Lutsenko, S. V., Severin, E. S., & Severin, E. S. (2003) · Biochemistry (Moscow) · doi:10.1023/a:1023984107503 · Cited by 7 · see citing works

Current Vascular Pharmacology

Grimm, D., Bauer, J., & Schoenberger, J. (2009) · MPG.PuRe (Max Planck Society)